亚甲蓝对脓毒症大鼠心肌损伤的保护作用及机制
该研究将32只雌性Wistar大鼠随机分为假手术组、脓毒症模型组、亚甲蓝预防组和亚甲蓝治疗组,每组8只,采用盲肠结扎穿孔术(CLP)建立脓毒症模型。亚甲蓝预防组在造模前6小时腹腔注射15 mg/kg亚甲蓝,亚甲蓝治疗组在造模后0.5小时腹腔注射15 mg/kg亚甲蓝,其余组注射等量生理盐水。结果显示,与脓毒症模型组相比,亚甲蓝治疗组在造模后6小时和12小时的心肌损伤标志物(cTnI、CK-MB)及炎症因子(TNF-α、IL-6)水平均显著降低(P<0.05),亚甲蓝预防组和治疗组心肌组织中iNOS、LC3和p62蛋白表达也显著降低(P<0.05)。作者认为亚甲蓝可能通过抑制iNOS表达和线粒体自噬减轻脓毒症大鼠心肌损伤。
要点
- 在CLP脓毒症大鼠中,造模后0.5小时腹腔注射15 mg/kg亚甲蓝,6小时和12小时cTnI、CK-MB、TNF-α、IL-6均显著低于模型组(P<0.05)。
- 亚甲蓝预防组(造模前6小时腹腔注射15 mg/kg)在6小时和12小时cTnI、CK-MB、TNF-α、IL-6与假手术组相比无显著变化。
- 亚甲蓝治疗组和预防组在6小时和12小时心肌iNOS、LC3、p62蛋白表达均显著低于模型组(P<0.05)。
- 光镜下亚甲蓝预防组6小时心肌炎症改变轻微,12小时加重但仍轻于模型组;治疗组6小时炎症改变较明显但轻于预防组12小时。
- 作者认为亚甲蓝可能通过抑制iNOS表达和线粒体自噬减轻脓毒症大鼠心肌损伤,对脓毒症心肌损伤有保护作用。
适用人群与场景
- 雌性Wistar大鼠,共32只,随机分为4组,每组8只。
- 脓毒症模型通过盲肠结扎穿孔术(CLP)建立;假手术组仅行开腹探查,不结扎穿刺盲肠。
处置流程与药物剂量
- 亚甲蓝预防组:造模前6小时腹腔注射15 mg/kg亚甲蓝。
- 亚甲蓝治疗组:造模后0.5小时腹腔注射15 mg/kg亚甲蓝。
- 其余3组:相应时间点腹腔注射4 mL/kg生理盐水。
- 造模后6小时和12小时采集外周血和心肌组织,检测血清cTnI、CK-MB、TNF-α、IL-6(ELISA法)及心肌iNOS、LC3、p62蛋白表达(Western blotting法)。
研究设计与关键结果
- 研究类型:动物实验;样本量:32只雌性Wistar大鼠,随机分为4组,每组8只。
- 与假手术组相比,亚甲蓝预防组造模后6小时和12小时cTnI、CK-MB、TNF-α、IL-6水平无显著变化。
- 与脓毒症模型组相比,亚甲蓝治疗组造模后6小时和12小时cTnI、CK-MB、TNF-α、IL-6水平均显著降低(均P<0.05):cTnI(ng/L)6小时为175.03±12.26、411.24±21.20 vs. 677.79±43.95,12小时为159.52±6.44、412.46±32.94 vs. 687.61±55.09;CK-MB(ng/L)6小时为8.38±0.49、16.87±1.41 vs. 24.87±1.74,12小时为7.94±0.30、16.66±2.03 vs. 25.02±7.29;TNF-α(ng/L)6小时为26.98±3.31、46.95±3.74 vs. 112.60±6.64,12小时为31.31±5.83、90.97±5.14 vs. 149.30±4.67;
- 与假手术组相比,脓毒症模型组造模后6小时和12小时心肌iNOS、LC3、p62蛋白表达显著升高。
- 与脓毒症模型组相比,亚甲蓝治疗组和预防组造模后6小时和12小时心肌iNOS、LC3、p62蛋白表达均显著降低(均P<0.05):iNOS/GAPDH 6小时为0.38±0.04、0.60±0.04 vs. 0.77±0.04,12小时为0.38±0.02、0.66±0.04 vs. 0.79±0.05;LC3/GAPDH 6小时为0.13±0.07、0.42±0.07 vs. 1.05±0.16,12小时为0.08±0.02、0.25±0.03 vs. 0.48±0.09;p62/GAPDH 6小时为0.17±0.05、0.44±0.10 vs. 1.19±0.07,12小时为0.07±0.00、0.28±0.08 vs. 0.69±0.02。
- 光镜下:假手术组心肌无明显异常;脓毒症模型组心肌明显炎症改变;亚甲蓝预防组造模后6小时心肌炎症改变轻微,12小时炎症改变严重但轻于脓毒症模型组;亚甲蓝治疗组造模后6小时心肌炎症改变较明显但轻于亚甲蓝预防组12小时,造模后12小时炎症改变较6小时减轻但仍重于亚甲蓝预防组6小时。
证据类型、等级与局限
- 证据类型:动物实验(大鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为亚甲蓝可能通过抑制iNOS表达和线粒体自噬减轻脓毒症大鼠心肌损伤,对脓毒症心肌损伤有保护作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the protective effect of methylene blue (MB) on myocardial injury in sepsis and its possible signaling pathway.
METHODS: A total of 32 female Wistar rats were randomly divided into sham operation group, sepsis model group, MB prevention group, and MB treatment group, with 8 rats in each group. The MB prevention group was injected with 15 mg/kg MB in the peritoneal cavity 6 hours before modeling; the other 3 groups were injected with 4 mL/kg saline in the peritoneal cavity. The sepsis model was established by cecal ligation puncture (CLP); the sham operation group was only subjected to an exploratory incision without ligation or puncture of the caecum. The MB treatment group was injected with 15 mg/kg MB in the peritoneal cavity 0.5 hours after modeling; the other 3 groups were injected with 4 mL/kg saline in the peritoneal cavity. Peripheral blood and myocardial tissue were collected from each group at 6 hours and 12 hours after modeling. Histological changes in the myocardial tissue were observed under the microscope; the levels of serum cardiac troponin I (cTnI), MB isoenzyme of creatine kinase (CK-MB), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) were detected by enzyme-linked immunosorbent assay (ELISA); and the expressions of inducible nitric oxide synthase (iNOS), light chain 3 (LC3), and p62 in the myocardial tissue were detected by Western blotting.
RESULTS: Under light microscopy, no obvious abnormalities were found in the myocardium of the sham operation group; the myocardium of the sepsis model group showed obvious inflammatory changes; the myocardium of the MB prevention group showed mild inflammatory changes at 6 hours after modeling, severe inflammatory changes at 12 hours but less severe than the sepsis model group; the myocardium of the MB treatment group showed more obvious inflammatory changes at 6 hours after modeling but less severe than the MB prevention group at 12 hours after modeling, and the inflammatory changes at 12 hours after modeling were alleviated but more severe than the 6 hours after modeling in MB prevention group. Compared with the sham operation group, the levels of cTnI, CK-MB, TNF-α and IL-6 in the MB prevention group at 6 hours and 12 hours after modeling were not significantly changed; compared with the sepsis model group, the cTnI, CK-MB, TNF-α and IL-6 levels in the MB treatment group at 6 hours and 12 hours after modeling were significantly lower [cTnI (ng/L): 175.03±12.26, 411.24±21.20 vs. 677.79±43.95 at 6 hours of modeling, 159.52±6.44, 412.46±32.94 vs. 687.61±55.09 at 12 hours of modeling; CK-MB (ng/L): 8.38±0.49, 16.87±1.41 vs. 24.87±1.74 at 6 hours of modeling, 7.94±0.30, 16.66±2.03 vs. 25.02±7.29 at 12 hours of modeling; TNF-α (ng/L): 26.98±3.31, 46.95±3.74 vs. 112.60±6.64 at 6 hours of modeling, 31.31±5.83, 90.97±5.14 vs. 149.30±4.67 at 12 hours of modeling; IL-6 (ng/L): 40.86±4.48, 128.90±3.14 vs. 248.90±12.76 at 6 hours of modeling, 80.13±7.94, 190.40±9.56 vs. 288.90±6.01 at 12 hours of modeling; all P < 0.05]. Western blotting showed that compared with the sham operation group, the protein expressions of iNOS, LC3, and p62 in the sepsis model group were significantly higher at 6 hours and 12 hours after modeling; compared with the sepsis model group, the protein expressions of iNOS, LC3, and p62 in the MB treatment group and MB prevention group were significantly lower at 6 hours and 12 hours after modeling (iNOS/GAPDH: 0.38±0.04, 0.60±0.04 vs. 0.77±0.04 at 6 hours of modeling; 0.38±0.02, 0.66±0.04 vs. 0.79±0.05 at 12 hours of modeling; LC3/GAPDH: 0.13±0.07, 0.42±0.07 vs. 1.05±0.16 at 6 hours of modeling; 0.08±0.02, 0.25±0.03 vs. 0.48±0.09 at 12 hours of modeling; p62/GAPDH: 0.17±0.05, 0.44±0.10 vs. 1.19±0.07 at 6 hours of modeling; 0.07±0.00, 0.28±0.08 vs. 0.69±0.02 at 12 hours of modeling; all P < 0.05).
CONCLUSIONS: MB can reduce myocardial oxidative stress by inhibiting iNOS expression and mitochondrial autophagy in septic rats, thereby alleviating myocardial damage in sepsis, and has protective effect on myocardial damage in sepsis.
参考来源
- Guo R, Tang W, Liu Y, et al. [Protective effect and mechanism of methylene blue on myocardial injury in rats with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38991962. doi:10.3760/cma.j.cn121430-20240227-00167
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。